Literature DB >> 28461135

Reproducibility, and sensitivity to motor unit loss in amyotrophic lateral sclerosis, of a novel MUNE method: MScanFit MUNE.

A B Jacobsen1, H Bostock2, A Fuglsang-Frederiksen1, L Duez1, S Beniczky1, A T Møller3, J U Blicher3, H Tankisi4.   

Abstract

OBJECTIVE: To examine inter- and intra-rater reproducibility and sensitivity to motor unit loss of a novel motor unit number estimation (MUNE) method, MScanFit MUNE (MScan), compared to two traditional MUNE methods; Multiple point stimulation MUNE (MPS) and Motor Unit Number Index (MUNIX).
METHODS: Twenty-two ALS patients and 20 sex- and age-matched healthy controls were included. MPS, MUNIX, and MScan were performed twice each by two blinded physicians. Reproducibility of MUNE values was assessed by coefficient of variation (CV) and intra class correlation coefficient (ICC). Ability to detect motor unit loss was assessed by ROC curves and area under the curve (AUC). The times taken for each of the methods were recorded.
RESULTS: MScan was more reproducible than MPS and MUNIX both between and within operators. The mean CV for MScan (12.3%) was significantly lower than for MPS (24.7%) or MUNIX (21.5%). All methods had ICC>0.94. MScan and Munix were significantly quicker to perform than MPS (6.3mvs. 13.2m). MScan (AUC=0.930) and MPS (AUC=0.899) were significantly better at discriminating between patients and healthy controls than MUNIX (AUC=0.831).
CONCLUSIONS: MScan was more consistent than MPS or MUNIX and better at distinguishing ALS patients from healthy subjects. SIGNIFICANCE: MScan may improve detection and assessment of motor unit loss.
Copyright © 2017 International Federation of Clinical Neurophysiology. All rights reserved.

Entities:  

Keywords:  ALS; MScanFit; MUNIX; Motor unit number estimation; Multiple point stimulation; Reproducibility

Mesh:

Year:  2017        PMID: 28461135     DOI: 10.1016/j.clinph.2017.03.045

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

1.  CMAP Scan MUNE (MScan) - A Novel Motor Unit Number Estimation (MUNE) Method.

Authors:  Anna B Jacobsen; Hugh Bostock; Hatice Tankisi
Journal:  J Vis Exp       Date:  2018-06-07       Impact factor: 1.355

2.  Motor unit number estimation of human abductor hallucis from a compound muscle action potential scan.

Authors:  Xiaoyan Li; Ya Zong; Cliff S Klein; Ping Zhou
Journal:  Muscle Nerve       Date:  2018-10-04       Impact factor: 3.217

3.  In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis.

Authors:  James Howells; José Manuel Matamala; Susanna B Park; Nidhi Garg; Steve Vucic; Hugh Bostock; David Burke; Matthew C Kiernan
Journal:  J Physiol       Date:  2018-10-17       Impact factor: 5.182

Review 4.  Biomarkers in Motor Neuron Disease: A State of the Art Review.

Authors:  Nick S Verber; Stephanie R Shepheard; Matilde Sassani; Harry E McDonough; Sophie A Moore; James J P Alix; Iain D Wilkinson; Tom M Jenkins; Pamela J Shaw
Journal:  Front Neurol       Date:  2019-04-03       Impact factor: 4.003

5.  Study protocol of RESCUE-ALS: A Phase 2, randomised, double-blind, placebo-controlled study in early symptomatic amyotrophic lateral sclerosis patients to assess bioenergetic catalysis with CNM-Au8 as a mechanism to slow disease progression.

Authors:  Steve Vucic; Matthew C Kiernan; Parvathi Menon; William Huynh; Austin Rynders; Karen S Ho; Robert Glanzman; Michael T Hotchkin
Journal:  BMJ Open       Date:  2021-01-11       Impact factor: 2.692

6.  Motor unit integrity in multifocal motor neuropathy: A systematic evaluation with CMAP scans.

Authors:  Diederik J L Stikvoort García; Maria O Kovalchuk; H Stephan Goedee; Leonard J van Schelven; Leonard H van den Berg; Hessel Franssen; Boudewijn T H M Sleutjes
Journal:  Muscle Nerve       Date:  2021-12-16       Impact factor: 3.852

7.  The evolving role of surface electromyography in amyotrophic lateral sclerosis: A systematic review.

Authors:  J Bashford; K Mills; C Shaw
Journal:  Clin Neurophysiol       Date:  2019-12-27       Impact factor: 3.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.